New product available in Canada for patients suffering from seasonal allergies

Good news for patients with seasonal allergies !!

GlaxoSmithKline Inc. introduced a new nasal spray, in fact, a first intranasal corticosteroid to be labeled for the relief of both nasal and ocular symptoms of seasonal allergic rhinitis, called 'AVAMYS' (fluticasone furoate nasal spray).

It is now available in Canada by prescription for patients 12 years of age and older. Avamys has a novel side-actuated ‘mist release’ button to make it easier to use by either the patient or their caregiver. It seems this product has an extra advantage that, it delivers a gentle,scent and taste-free mist with low volume of spray, so patient are less likely to experience a bitter taste or the effects of drip down the back of the throat. This product consistently demonstrated,in several clinical studies, an improvement in the relief of nasal and ocular symptoms associated with seasonal allergic rhinitis. This is really welcome news for most of the Canadian patients suffering from seasonal allergies.

So far ‘Fluticasone propionate’ (Flovent HFA) was available in oral inhalation form….and this new product ( Avamys ) would probably provide more benefits to people who have been looking for better alternatives.

Avamys is available in 120 metered sprays pack size with 27.5 mcg of 'fluticasone furoate' per metered spray. Hope Avamys would bring extra benefits to patients who are suffering from seasonal allergies…….